Two other studies suggested that miR-27a may be involved in the development of tumor drug resistance [25] and we were interested in miR-27a because of its involvement in MDR/P-glycoprotein expression in cancer cells, a typical characteristic of many RCCs. This evidence concerns the gene ABCB1 and neoplasm.